Christopher L. Wolfgang

7.1k total citations
62 papers, 2.0k citations indexed

About

Christopher L. Wolfgang is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Christopher L. Wolfgang has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 23 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Christopher L. Wolfgang's work include Pancreatic and Hepatic Oncology Research (49 papers), Cancer Genomics and Diagnostics (14 papers) and Pancreatitis Pathology and Treatment (12 papers). Christopher L. Wolfgang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (49 papers), Cancer Genomics and Diagnostics (14 papers) and Pancreatitis Pathology and Treatment (12 papers). Christopher L. Wolfgang collaborates with scholars based in United States, Netherlands and China. Christopher L. Wolfgang's co-authors include Elizabeth M. Jaffee, Lei Zheng, Daniel A. Laheru, Robert A. Anders, Kevin C. Soares, Elaine Bigelow, Annie A. Wu, Eric R. Lutz, Jin He and Agnieszka A. Rucki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher L. Wolfgang

56 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher L. Wolfgang United States 21 1.6k 753 399 322 308 62 2.0k
Ursina Teitelbaum United States 19 1.9k 1.2× 1.2k 1.6× 596 1.5× 452 1.4× 275 0.9× 54 2.7k
Andrew L. Coveler United States 22 1.1k 0.7× 607 0.8× 481 1.2× 268 0.8× 135 0.4× 105 1.7k
Dan Laheru United States 19 1.4k 0.9× 668 0.9× 505 1.3× 298 0.9× 258 0.8× 69 2.1k
Jonathan J. Havel United States 13 1.9k 1.2× 1.1k 1.4× 825 2.1× 493 1.5× 222 0.7× 14 2.7k
Sofia R. Gameiro United States 28 1.9k 1.2× 1.5k 2.0× 609 1.5× 208 0.6× 157 0.5× 59 2.7k
Arantza Fariña Sarasqueta Netherlands 22 1.0k 0.6× 227 0.3× 437 1.1× 284 0.9× 383 1.2× 83 1.8k
Alice Pons United States 5 2.4k 1.5× 1.3k 1.7× 411 1.0× 225 0.7× 229 0.7× 8 2.8k
Orianne Colussi France 6 1.2k 0.7× 741 1.0× 475 1.2× 293 0.9× 103 0.3× 10 1.8k
Valerie Chew Singapore 19 1.3k 0.8× 1.2k 1.6× 491 1.2× 367 1.1× 183 0.6× 37 2.4k
Elizabeth Stankevich United States 15 2.4k 1.5× 1.3k 1.7× 416 1.0× 192 0.6× 189 0.6× 39 2.9k

Countries citing papers authored by Christopher L. Wolfgang

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Wolfgang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Wolfgang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Wolfgang more than expected).

Fields of papers citing papers by Christopher L. Wolfgang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Wolfgang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Wolfgang. The network helps show where Christopher L. Wolfgang may publish in the future.

Co-authorship network of co-authors of Christopher L. Wolfgang

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Wolfgang. A scholar is included among the top collaborators of Christopher L. Wolfgang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Wolfgang. Christopher L. Wolfgang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salinas, C, Christopher L. Wolfgang, & Joseph R. Habib. (2025). Clinical and radiological predictive features for high‐grade and invasive carcinoma in intraductal papillary mucinous neoplasms: A systematic review. Journal of Hepato-Biliary-Pancreatic Sciences. 33(1). 8–20. 2 indexed citations
2.
3.
Hewitt, D. Brock, John F. P. Bridges, Ammar A. Javed, et al.. (2024). Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous Neoplasms. Annals of Surgery. 283(1). 149–153.
4.
Habib, Joseph R., Shuang Zhang, D. Brock Hewitt, et al.. (2024). Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm–derived Pancreatic Cancer. Annals of Surgery. 282(6). 1052–1059. 9 indexed citations
5.
Winner, Megan, John Allendorf, Paresh C. Shah, et al.. (2024). Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer Database. World Journal of Surgery. 49(1). 262–269. 1 indexed citations
6.
Wang, Junke, Jie Yang, Amol Narang, et al.. (2024). Consensus, debate, and prospective on pancreatic cancer treatments. Journal of Hematology & Oncology. 17(1). 92–92. 39 indexed citations
7.
Garnier, Jonathan, Karan Garg, Jamie P. Levine, et al.. (2024). Two-Stage Mayo Clinic Class IIIb Celiac Axis Resection for Pancreatic Adenocarcinoma: Stepwise Management. Annals of Surgical Oncology. 32(4). 2476–2478. 1 indexed citations
8.
Habib, Joseph R., Ammar A. Javed, Benedict Kinny‐Köster, et al.. (2024). Outcomes in intraductal papillary mucinous neoplasm‐derived pancreatic cancer differ from PanIN‐derived pancreatic cancer. Journal of Gastroenterology and Hepatology. 39(11). 2360–2366. 7 indexed citations
9.
Xia, Tao, Keyu Li, Nan Niu, et al.. (2022). Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses. Journal of Hematology & Oncology. 15(1). 37–37. 49 indexed citations
10.
11.
Oosten, A. Floortje van, Ding Ding, Joseph R. Habib, et al.. (2020). Perioperative Outcomes of Robotic Pancreaticoduodenectomy: a Propensity-Matched Analysis to Open and Laparoscopic Pancreaticoduodenectomy. Journal of Gastrointestinal Surgery. 25(7). 1795–1804. 50 indexed citations
12.
Blair, Alex B., Victoria M. Kim, Stephen Muth, et al.. (2019). Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. Clinical Cancer Research. 25(17). 5351–5363. 64 indexed citations
13.
Abe, Toshiya, Shiro Kohi, Ki Byung Song, et al.. (2019). Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer. Clinical Gastroenterology and Hepatology. 18(5). 1161–1169.e5. 38 indexed citations
14.
Ryan, John F., Vincent P. Groot, Lauren M. Rosati, et al.. (2017). Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective. Annals of Surgical Oncology. 25(1). 280–289. 25 indexed citations
15.
Xiao, Qian, Donger Zhou, Agnieszka A. Rucki, et al.. (2016). Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation. Cancer Research. 76(18). 5395–5404. 92 indexed citations
16.
Wild, Aaron T., Joseph M. Herman, Avani Satish Dholakia, et al.. (2015). Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(3). 571–579. 167 indexed citations
17.
Lutz, Eric R., Annie A. Wu, Elaine Bigelow, et al.. (2014). Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation. Cancer Immunology Research. 2(7). 616–631. 399 indexed citations
18.
Soares, Kevin C., Agnieszka A. Rucki, Annie A. Wu, et al.. (2014). PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors. Journal of Immunotherapy. 38(1). 1–11. 316 indexed citations
19.
Moningi, Shalini, Elwood P. Armour, Stephanie A. Terezakis, et al.. (2014). High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program. Journal of Contemporary Brachytherapy. 1(1). 99–105. 7 indexed citations
20.
Chen, Ru, Sheng Pan, Niki A. Ottenhof, et al.. (2012). Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biology & Therapy. 13(10). 899–907. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ursina Teitelbaum Breakdown of academic impact, for papers by Andrew L. Coveler Breakdown of academic impact, for papers by Dan Laheru Breakdown of academic impact, for papers by Jonathan J. Havel Breakdown of academic impact, for papers by Sofia R. Gameiro Breakdown of academic impact, for papers by Arantza Fariña Sarasqueta Breakdown of academic impact, for papers by Alice Pons Breakdown of academic impact, for papers by Orianne Colussi Breakdown of academic impact, for papers by Valerie Chew Breakdown of academic impact, for papers by Elizabeth Stankevich
Rankless by CCL
2026